UIC startup raises nearly $1M to help develop safer leukemia chemotherapy
A startup company founded by UIC researchers in the department of biochemistry and molecular genetics, recently has secured nearly $1 million in total funding to help it further develop a less toxic version of chemotherapy commonly used to treat acute lymphoblastic leukemia.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
